Section of Gastroenterology
Assistant Professor of Medicine
Referring Physician Access Line: 1-877-DOM-2730
|BA||1998||Brown University||Latin American History and Biology
|MD||2003||University of Illinois College of Medicine||Medicine
|Residency||2004||Massachusetts General Hospital||Internal Medicine
|Fellowship||2010||University of Chicago||Gastroenterology
Dr. Pekow investigates mechanisms of colon cancer development in patients with IBD. He is interested in using novel molecular methods to provide significant insights into why cancers develop in this population. He hopes this knowledge will lead to the development of new markers for precancerous lesions, and ultimately to cancer prevention in IBD patients.
Dr. Pekow specializes in the treatment of digestive disorders, with a particular focus on inflammatory bowel disease (IBD) and colon cancer screening.
- Pekow J, Chung RT. Treatment of Type II Mixed Cryoglobulinemia Associated with Hepatitis C with Rituximab. J Clin Gastroenterol 2006 May-Jun;40(5):450.
- Pekow J, Bhan AK, Zheng H, Chung RT. Hepatic Steatosis is Associated with Increased Frequency of Hepatocellular Carcinoma in Patients with Hepatitis C-Related Cirrhosis. Cancer 2007 Jun 15;109(12):2490-6.
- Pekow J, Hetzel JT, Rothe JA, Turner J, Noffsinger A, Hart J, Hanauer S, Huo D, Rubin DT. Outcome After Surveillance of Low Grade and Indefinite Dysplasia in Patients with Ulcerative Colitis. Inflamm Bowel Dis 2010 Aug;16(8):1352-6.